Gait and Bone Health in SMA
Recruiting now
Conditions studied: Spinal Muscular Atrophy Type 3, Ambulatory Spinal Muscular Atrophy
In brief
The objective of this study is to understand how spatiotemporal and kinetic gait parameters are associated with bone health in pwSMA who are receiving DMT. We hypothesize that gait parameters are associated with BMD and can determine fracture risk in pwSMA. This is an observational study that involves one in-clinic visit (approximately 3 hours) with remote follow-up visits (approximately 15 minutes) every 3 months for 1 year to collect fracture and medical history. Each of the assessments included in this study are non-interventional and are not intended as a treatment nor are they at the level of standard of care.
Key facts
- Study ID
- NCT07400198
- Run by
- Jacqueline Montes
- People needed
- 22
- Starts
- 2026-03-05
- Expected to finish
- 2027-06-30
- Last updated by the study team
- 2026-03-18
Who can join
Age: 8 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed diagnosis of 5qSMA
- Between 8 and 50 years of age
- Able to walk 10 meters without support or an assistive device
- All participants who meet the inclusion criteria regardless of treatment status will be included, including those on adjuvant therapies, whether investigational or approved
You may not qualify if…
- Injury or surgery within previous 3 months that would impact ability to perform in-clinic gait assessments
- Unwilling or unable to comply with all study procedures
- Age less than 8 or over 50 years
Where it is running
- Columbia University Irving Medical Center — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.